Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus infection

J A Molinari1

  • 1Department of Biomedical Sciences, University of Detroit Mercy School of Dentistry, Michigan, USA.

Dental Clinics of North America
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) infection, primarily spread through blood, is now mainly linked to IV drug use in the US. Universal precautions effectively protect healthcare workers from occupational HCV exposure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New tuberculosis vaccines: prospects for reversing worldwide trends.

Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)·2002
Same author

Clinic jackets and gowns: a misunderstood personal protection equipment requirement?

Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)·2002
Same author

The immunocompromised health care professional.

Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)·2002
Same author

Surface disinfectants: read the labels.

Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)·2002
Same author

Dental unit water contamination.

Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)·2001
Same author

Evaluation of a hydrogen peroxide disinfectant for dental unit waterlines.

Journal of the American Dental Association (1939)·2001
Same journal

Contemporary Oral and Maxillofacial Trauma: A Dental Perspective.

Dental clinics of North America·2026
Same journal

The Expanding Role of Virtual Surgical Planning in Maxillofacial Trauma Management.

Dental clinics of North America·2026
Same journal

Revision Surgery for Occlusal Correction in Facial Trauma.

Dental clinics of North America·2026
Same journal

Mandibular Condylar Fractures and Occlusal Management.

Dental clinics of North America·2026
Same journal

Occlusion Management in Facial Trauma: A Literature Review.

Dental clinics of North America·2026
Same journal

Dental Implants in Rehabilitation of Patients with Facial Trauma: a Review of Most Current Practices.

Dental clinics of North America·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C is caused by a single-stranded RNA virus (HCV).
  • Historically, blood transfusions were the primary transmission route, but parenteral drug abuse is now the leading cause in the US.
  • Hepatitis C shares epidemiologic traits with Hepatitis B, with blood-borne transmission being a key factor.

Purpose of the Study:

  • To review the epidemiology and transmission of Hepatitis C.
  • To assess occupational risks for healthcare workers and the effectiveness of infection control.
  • To discuss ongoing research into interferon therapy for chronic Hepatitis C.

Main Methods:

  • Literature review of Hepatitis C transmission and epidemiology.
  • Analysis of risk factors, including blood transfusions and intravenous drug use.

Related Experiment Videos

  • Evaluation of infection control measures and occupational hazards for healthcare professionals.

    • Main Results:

    • Parenteral drug abuse is the predominant risk factor for Hepatitis C infection in the United States.
    • Healthcare worker risk from needlestick injuries is significantly lower than for Hepatitis B.
    • Universal bloodborne precautions are effective in preventing occupational cross-infection.

    Conclusions:

    • Hepatitis C transmission dynamics have shifted, with IV drug use now being the primary driver.
    • Current infection control strategies adequately protect healthcare workers.
    • Further research is exploring interferon therapy's efficacy in managing chronic Hepatitis C and reducing liver damage.